Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Promising preclinical data reported on BT-2111

June 12, 2012

Ubidecarenone investigated for oncolytic activity

June 12, 2012

Dosing begins in phase III palifosfamide study

June 11, 2012

Cancer Research UK opens phase Ib/IIa trial of AstraZeneca drug

June 11, 2012

FDA approves Roche antibody for use in combination cancer therapy

June 11, 2012

MMRF awards funding to Modulation Therapeutics for MTI-101

June 11, 2012

Fluorinov Pharma obtains funding to support development of FV-162

June 11, 2012

New TYK2 inhibitors designed at Cellzome

June 11, 2012

ORCA Therapeutics' lead product set to enter clinic

June 11, 2012

New fatty acid synthase inhibitors patented by GlaxoSmithKline

June 11, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 29, 2026.
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...
GT-02897 exerts efficacy in preclinical multiple myeloma
BioWorld Science
Investigators from the Karl Landsteiner University aimed to evaluate the therapeutic potential of a novel CDK9 inhibitor/degrader, GT-02897, for the potential...